Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply.
Domains
Santé publique et épidémiologie| Origin | Files produced by the author(s) |
|---|---|
| Licence |
Journal Articles
Alimentary Pharmacology & Therapeutics (Suppl)
Year : 2021
Gestionnaire HAL 3 Sorbonne Université : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03776245
Submitted on : Tuesday, September 13, 2022-3:10:47 PM
Last modification on : Thursday, November 7, 2024-2:21:37 PM
Long-term archiving on : Wednesday, December 14, 2022-6:25:08 PM
Dates and versions
Licence
Identifiers
- HAL Id : hal-03776245 , version 1
- DOI : 10.1111/apt.16251
- PUBMED : 33566398
Cite
Stanislas Pol, Clovis Luzivika Nzinga, Hélène Fontaine, Fabrice Carrat. Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply.. Alimentary Pharmacology & Therapeutics (Suppl), 2021, 53 (5), pp.659. ⟨10.1111/apt.16251⟩. ⟨hal-03776245⟩
Collections
72
View
23
Download